Epidemiology of iron deficiency anaemia in four European countries: a population-based study in primary care

2016 ◽  
Vol 97 (6) ◽  
pp. 583-593 ◽  
Author(s):  
Miriam Levi ◽  
Matteo Rosselli ◽  
Monica Simonetti ◽  
Ovidio Brignoli ◽  
Maurizio Cancian ◽  
...  
PLoS ONE ◽  
2013 ◽  
Vol 8 (10) ◽  
pp. e78162 ◽  
Author(s):  
Thach Duc Tran ◽  
Beverley-Ann Biggs ◽  
Tuan Tran ◽  
Gerard J. Casey ◽  
Sarah Hanieh ◽  
...  

2015 ◽  
Vol 66 (2-3) ◽  
pp. 80-92 ◽  
Author(s):  
Simone Eussen ◽  
Martine Alles ◽  
Lieke Uijterschout ◽  
Frank Brus ◽  
Judith van der Horst-Graat

Background: Iron deficiency is the most common nutritional disorder in the world. Young children are particularly vulnerable to the consequences of iron deficiency because of their rapidly developing brain. This review evaluates the prevalence of inadequate iron intake and iron deficiency (anaemia) in European children aged 6-36 months. Summary: Computerized searches for relevant articles were performed in November 2013. A total of 7,297 citations were screened and 44 studies conducted in 19 European countries were included in this review. In both infants (6-12 months) and young children (12-36 months), the mean value of iron intakes in most countries was close to the RDA. Nevertheless, proportions of inadequate intakes were considerable, ranging from about 10% in the Netherlands up to 50% in Austria, Finland and the United Kingdom. The prevalence of iron deficiency varied between studies and was influenced by children's characteristics. Two to 25% of infants aged 6-12 months were found to be iron deficient, with a higher prevalence in those who were socially vulnerable and those who were drinking cow's milk as a main type of drink in their first year of life. In children aged 12-36 months, prevalence rates of iron deficiency varied between 3 and 48%. Prevalence of iron deficiency anaemia in both age groups was high in Eastern Europe, as high as 50%, whereas the prevalence in Western Europe was generally below 5%. Key Messages: In most European countries, mean iron intakes of infants and children aged 6 to 36 months were found to be close to the RDA. Nevertheless, high proportions of inadequate intakes and high prevalence rates of iron deficiency were observed. Health programs should (keep) focus(ing) on iron malnutrition by educating parents on food choices for their children with iron-rich and iron-fortified foods, and encourage iron supplementation programmes where iron intakes are the lowest.


2019 ◽  
Vol 98 (7) ◽  
pp. 1573-1582 ◽  
Author(s):  
Miriam Levi ◽  
Monica Simonetti ◽  
Ettore Marconi ◽  
Ovidio Brignoli ◽  
Maurizio Cancian ◽  
...  

BMJ Open ◽  
2020 ◽  
Vol 10 (3) ◽  
pp. e034202
Author(s):  
Fang-Jen Wu ◽  
I-Hsun Li ◽  
Wu-Chien Chien ◽  
Jui-Hu Shih ◽  
Yi-Chun Lin ◽  
...  

ObjectivesThe administration of androgen deprivation therapy (ADT) to patients with metastatic prostate cancer might be associated with some adverse effects such as anaemia; however, few studies have been performed in East Asian populations. This study aimed to investigate the association between ADT and iron-deficiency anaemia (IDA) among patients with prostate cancer in a population-based nationwide cohort.DesignCohort study.SettingTaiwan.ParticipantsData for the cohort study were retrieved from the Taiwan National Health Insurance Research Database. Propensity score matching was used to select 7262 patients with prostate cancer who received ADT as the study group and 3631 patients who did not receive ADT as the control group.Primary and secondary outcome measuresThis study individually tracked patients over a 3-year study period and identified those who were subsequently diagnosed with IDA following the index date.ResultsThe incidence rates of IDA in the study and control groups were 1.66 (95% CI CI 1.45 to 1.86) and 1.01 per 100 person-years (95% CI 0.78 to 1.25), respectively. Furthermore, proportional Cox regression revealed an HR of 1.62 (95% CI 1.24 to 2.12) for IDA in the study group after adjusting for patients’ age, monthly income, geographic location, residential urbanisation level and incidence of hyperlipidaemia, diabetes, hypertension, coronary heart disease, inflammatory bowel disease, other cancers and gastrointestinal bleeding.ConclusionCompared with its non-use among patients with prostate cancer, ADT use was associated with a higher risk of IDA.


2021 ◽  
Vol 32 (9) ◽  
pp. 358-362
Author(s):  
Margaret Perry

Iron deficiency anaemia and anaemia of chronic disease are commonly seen in primary care. Margaret Perry discusses how to recognise, diagnose and manage these conditions This article will look at iron deficiency anaemia and anaemia of chronic disease. Both are problems encountered frequently at a global scale and in the primary care setting. Both conditions can potentially affect any age, although anaemia of chronic disease is more common among older adults. It is hoped that the information provided will give general practice nurses and nurse prescribers greater confidence in the recognition, diagnosis, and management of these conditions, to improve patient care.


Sign in / Sign up

Export Citation Format

Share Document